Expression of T-cadherin in tumor cells influences invasive potential of human hepatocellular carcinoma
Overexpression of T-cadherin (T-cad) transcripts occurs in [almost equal to]50% of human hepatocellular carcinomas (HCCs). To elucidate T-cad functions in HCC, we examined T-cad protein expression in normal and tumoral human livers and hepatoma cell lines and investigated its influence on invasive p...
Saved in:
Published in | The FASEB journal Vol. 20; no. 13; pp. 2291 - 2301 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
The Federation of American Societies for Experimental Biology
01.11.2006
|
Subjects | |
Online Access | Get more information |
Cover
Loading…
Summary: | Overexpression of T-cadherin (T-cad) transcripts occurs in [almost equal to]50% of human hepatocellular carcinomas (HCCs). To elucidate T-cad functions in HCC, we examined T-cad protein expression in normal and tumoral human livers and hepatoma cell lines and investigated its influence on invasive potential of HCC using RNA interference silencing of T-cad expression in Mahlavu cells. Whereas T-cad expression was restricted to endothelial cells (EC) from large blood vessels in normal livers, it was up-regulated in sinusoidal EC from 8/15 invasive HCCs. Importantly, in three of them (38%) T-cad was detected in tumor cells within regions in which E-cadherin expression was absent. Among six hepatoma cell lines, only Mahlavu expressed T-cad but not E-cadherin. T-cad exhibited a globally punctuate distribution in quiescent Mahlavu and additionally it concentrated at the leading edge of migrating cells. Matrigel invasion assay revealed that Mahlavu possess a high invasive potential that was significantly inhibited by T-cad silencing. Wound healing and random motility assays demonstrated that inhibition of T-cad expression in Mahlavu significantly reduced their motility. We propose that T-cad expression in tumor cells might occur by cadherin-switching during epithelial-mesenchymal transition and may represent an additional mechanism contributing to HCC metastasis.--Riou, P., Saffroy, R., Chenailler, C., Franc, B., Gentile, C., Rubinstein, E., Resink, T., Debuire, B., Piatier-Tonneau, D., Lemoine, A. Expression of T-cadherin in tumor cells influences invasive potential of human hepatocellular carcinoma. |
---|---|
Bibliography: | http://www.fasebj.org/ |
ISSN: | 0892-6638 1530-6860 |
DOI: | 10.1096/fj.06-6085com |